Abstract
Resveratrol (RVS) is a naturally occurring antioxidant, able to display an array of biological activities. In the present investigation, a new derivative of RVS, RVS(a), was synthesized, and its biological activity was determined on U937 cells. It was observed that RVS(a) showed pronounced activity on U937 cells than RVS. RVS(a) is able to induce apoptosis in tumor cell lines through subsequent DNA fragmentation. From the EMSA results, it was evident that RVS(a) was able to suppress the activity of NFkB by interfering its DNA binding ability. Furthermore, the molecular interaction analysis (docking and dynamics) stated that RVS(a) has strong association with the IkB-alpha site of NFkB compared with RVS; this binding nature of RVS(a) might be prevent the NFkB binding ability with DNA. The present findings represent the potential activity of propynyl RVS on U937 cells and signifying it as a one of putative chemotherapeutic drugs against cancer.
Similar content being viewed by others
References
Aziz, M. H., Kumar, R., & Ahmad, N. (2003). International Journal of Oncology, 23, 17–28.
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., & Pezzuto, J. M. (1997). Science, 275, 218–220.
Khan, N., Afaq, F., & Mukhtar, H. (2008). Antioxidants & Redox Signaling, 10, 475–510.
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G., & Goldberg, D. M. (1995). Clinca Chimica Acta, 235, 207–219.
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993). Lancet, 341, 1103–1104.
Huang, C., Ma, W. Y., Goranson, A., & Zong, D. (1999). Carcinogenesis, 20, 237–242.
Kundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y. J. (2006). Carcinogenesis, 27, 1465–1474.
Mukherjee, S., Dudley, J. I., & Das, D. K. (2010). Dose Response, 8, 478–500.
Choi, Y. J., Yang, K. M., Kim, S. D., Yoo, Y. H., Lee, S. W., Seo, S. Y., Suh, H., Yee, S. T., Jeong, M. H., & Jo, W. S. (2012). Experimental and Therapeutic Medicine, 3, 592–598.
Marier, J.-F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J. P., & Ducharme, M. P. (2002). Journal of Pharmacology and Experimental Therapeutics, 302, 369–373.
Yu, C., Shin, Y. G., Chow, A., Li, Y., Kosmeder, J. W., Lee, Y. S., Hirschelman, W. H., Pezzuto, J. M., Mehta, R. G., & van Breemen, R. B. (2002). Pharmaceutical Research, 19, 1907–1914.
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Jr Walle, U. K. (2004). Drug Metabolism and Disposition, 32, 1377–1382.
Piotrowska, H., Myszkowski, K., Ziółkowska, A., Kulcenty, K., Wierzchowski, M., Kaczmarek, M., Murias, M., Kwiatkowska-Borowczyk, E., & Jodynis-Liebert, J. (2012). Toxicology and Applied Pharmacology, 263, 53–60.
Fujisawa, S., & Kadoma, Y. (2006). Chemosphere, 62, 71–79.
Zhang, L., Jing, H., Cui, L., Li, H., Zhou, B., Zhou, G., & Dai, F. (2013). Journal of Cellular Biochemistry, 114, 697–707.
Mayhoub, A. S., Marler, L., Kondratyuk, T. P., Park, E. J., Pezzuto, J. M., & Cushman, M. (2012). Bioorgnic Medicinal Chemistry, 20, 510–520.
Jeong, S. H., Jo, W. S., Song, S., Suh, H., Seol, S. Y., Leem, S. H., Kwon, T. K., & Yoo, Y. H. (2009). Biochemical. Pharmacology, 77, 1337–1347.
Lipinski, C. A. (2000). Journal of Pharmacological and Toxicological Methods, 44, 235–249.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Advanced Drug Delivery Reviews, 23, 3–25.
Li, A. P., & Segall, M. (2002). Drug Discovery Today, 7, 25–27.
Berg, K., Hansen, M. B., & Nielsen, S. E. (1990). Acta Pathologica. Microbiologica et Immunologica Scandinavica, 98, 156–162.
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. (2000). Journal of Immunology, 164, 6509–6519.
Chan, J. Y., Phoo, M. S., Clement, M. V., Pervaiz, S., & Lee, S. C. (2008). Cancer Biology & Therapy, 7, 1305–1312.
Park, J. W., Choi, Y. J., Suh, S. I., Baek, W. K., Suh, M. H., Jin, I. N., Min, D. S., Woo, J. H., Chang, J. S., Passaniti, A., Lee, Y. H., & Kwon, T. K. (2001). Carcinogenesis, 22, 1633–1639.
Walsh, G. M., Grant, D., Andrew, J., Wardlaw, J., Levi-Schaffer, F., & Moqbel, R. (1998). Journal of Immunological Methods, 217, 153–163.
Huxford, T., Huang, D. B., Malek, S., & Ghosh, G. (1998). Cell, 95, 759–770.
Berendsen, H. J., Postma, J. P. M., VanGunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Journal of Chemical Physics, 81, 3584–3590.
Lindahl, E., Hess, B., & VanDerSpoe, D. (2001). Journal of Molecular Modeling, 7, 306–317.
Schüttelkopf, A. W., & van Aalten, D. M. (2004). Acta Crystallographica Section D: Biological Crystallography, 60, 1355–1363.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Journal Computational Chemistry, 16, 2785–2791.
Babajan, B., Chaitanya, M., Rajsekhar, C., Gowsia, D., Madhusudhana, P., Naveen, M., Chitta, S. K., & Anuradha, C. M. (2011). Interdisciplinary Sciences: Computational Life Sciences, 3, 204–216.
Hess, B., Kutzner, C., Spoel, D. V. D., & Lindahl, E. (2008). Journal of Chemical Theory and Computation, 4, 435–447.
Chandrasekhar, I., Kastenholz, M., Lins, R. D., Oostenbrink, C., Schuler, L. D., Tieleman, D. P., & van Gunsteren, W. F. (2003). European Biophysics Journal, 32, 67–77.
Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). Computer Physics Communications, 91, 43–56.
Berendsen, H. J. C., Postma, J., van Gunsteren, W. F., & Hermans, J. (1981) In: Intermolecular forces (Pullman, B., and Reidel, D., eds), Dordrecht, The Netherland, pp. 331–342
Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). Journal of Computatinal Chemistry, 18, 1463–1472.
Darden, T., York, D., & Pedersen, L. (1993). Journal of Chemical Physics, 98, 10089–10092.
Essman, U., Perela, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). Journal of Chemical Physics, 103, 8577–8593.
Mukherjee, A., & Bagchi, B. (2003). Journal of Chemical Physics, 118, 4733–4747.
Dong, Z. (2003). Mutatation Research, 523–524, 145–150.
Lu, J., Ho, C. H., Ghai, G., & Chen, K. Y. (2001). Carcinogenesis, 22, 321–328.
Castello, L., & Tessitore, L. (2005). Oncology Report, 13, 133–137.
Minutolo, F., Sala, G., Bagnacani, A., Bertini, S., Carboni, I., Placanica, G., Prota, G., Rap Poselli, S., Sacchi, N., Macchia, M., & Ghidoni, R. (2005). Journal of Medicinal Chemistry, 48, 6783–6786.
Simoni, D., Roberti, M., Invidiata, F. P., Aiello, E., Aiello, S., Marchetti, P., Baruchello, R., Eleopra, M., Di Cristina, A., Grimaudo, S., Gebbia, N., Crosta, L., & Dieli, M. (2006). Bioorgnic Medicinal Chemistry Letters, 16, 3245–3248.
Wen, X., & Walle, T. (2006). Drug Metabolism and Disposition, 34, 1786–1792.
Aggarwal, B. B. (2004). Cancer Cell, 6, 203–208.
Acknowledgments
This work is majorly supported by the Department of Biotechnology (DBT) Bioinformatics Infrastructure Facility (BIF) (F. No. BT/BI/25/2001/2006). We gratefully acknowledge Dr. Sunil Kumar Manna, Scientist-IV, and Dr. J. Gowrishankar, Director of CDFD, Hyderabad, for providing opportunity to perform in vitro studies of our synthesized compound. The author Dr. B. Babajan (No. F.4-2/2006 (BSR)/13-843/2013 (BSR) thanks UGC’s Dr. D.S. Kothari, Post-doctoral program, for providing financial assistance. P. Madhusdana (Lr. No. 45/20/2011-BMS/BIF) thanks to ICMR for providing financial assistance.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Supplementary Fig. 1
Schematic of synthesis of RVS derivative (RVS (a)) (JPEG 254 kb)
Supplementary Fig. 2
Assigned spectra for RVS (a) 400 MHz 1H spectrum (JPEG 122 kb)
Rights and permissions
About this article
Cite this article
Banaganapalli, B., Mulakayala, C., D, G. et al. Synthesis and Biological Activity of New Resveratrol Derivative and Molecular Docking: Dynamics Studies on NFkB. Appl Biochem Biotechnol 171, 1639–1657 (2013). https://doi.org/10.1007/s12010-013-0448-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0448-z